Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)

.

Saved in:
Bibliographic Details
Main Author: article Editorial
Format: Article
Language:Russian
Published: IMA PRESS LLC 2022-11-01
Series:Научно-практическая ревматология
Online Access:https://rsp.mediar-press.net/rsp/article/view/3231
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043021094027264
author article Editorial
author_facet article Editorial
author_sort article Editorial
collection DOAJ
description .
format Article
id doaj-art-e76c8c9f4a4b4101be9b0edd5eae4ba8
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2022-11-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-e76c8c9f4a4b4101be9b0edd5eae4ba82025-08-20T02:55:20ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922022-11-016056096112852Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)article Editorial.https://rsp.mediar-press.net/rsp/article/view/3231
spellingShingle article Editorial
Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
Научно-практическая ревматология
title Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
title_full Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
title_fullStr Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
title_full_unstemmed Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
title_short Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
title_sort problems in the treatment of rheumatoid arthritis and prospects for the use of an il 1 inhibitor anakinra resolution of the expert council may 19 2022
url https://rsp.mediar-press.net/rsp/article/view/3231
work_keys_str_mv AT articleeditorial problemsinthetreatmentofrheumatoidarthritisandprospectsfortheuseofanil1inhibitoranakinraresolutionoftheexpertcouncilmay192022